Código QR (código de barras bidimensional)

Real-World Utilization Patterns, Safety, and Efficacy of Tafamidis in Patients With Hereditary Transthyretin Amyloidosis in Japan

ABSTRACT: Purpose: Patients with hereditary transthyretin (ATTRv) amyloidosis experience progressive degeneration of the somatic and peripheral nervous system that can impair ambulation, autonomy, and quality of life (QOL). Tafamidis meglumine (tafamidis) is the first pharmacotherapy approved to sl...

ver descrição completa

Na minha lista:
Principais autores: Hiroaki Konishi, PharmD, Hajime Abe, MD, PhD, Noriko Matsumoto, Yutaka Endo, Yoshiki Sekijima, MD, PhD, Mitsuharu Ueda, MD, PhD, Yukio Ando, MD, PhD
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2025-01-01
coleção:Current Therapeutic Research
Assuntos:
Efficacy
Hereditary transthyretin amyloidosis
Japan
Postmarketing surveillance
Safety
Tafamidis meglumine
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S0011393X25000189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados